somber illustration of Atlanta Braves' Jurickson Profar in dugout with MLB 162-game PED suspension notice.
somber illustration of Atlanta Braves' Jurickson Profar in dugout with MLB 162-game PED suspension notice.
AI 生成的图像

Jurickson Profar suspended 162 games for second PED violation

AI 生成的图像

Major League Baseball suspended Atlanta Braves designated hitter Jurickson Profar for 162 games on Tuesday after he tested positive for exogenous testosterone and its metabolites. This marks his second violation of the league's Joint Drug Prevention and Treatment Program, following an 80-game ban in 2025. The suspension, effective Friday, March 6, bars him from the entire 2026 season, postseason, and the World Baseball Classic.

Jurickson Profar, who signed a three-year, $42 million contract with the Atlanta Braves in January 2025 after a standout 2024 season with the San Diego Padres, faced his second positive test for a performance-enhancing drug. In 2024, Profar earned All-Star and Silver Slugger honors, hitting .280 with a .380 on-base percentage, 24 home runs, and 85 RBI. However, his time with the Braves has been disrupted by PED issues.

On March 31, 2025, Profar tested positive for human chorionic gonadotropin, resulting in an 80-game suspension that made him ineligible for the postseason. He played four games before the ban and, upon return on July 2, batted .245/.353/.434 over 80 games, recording 14 home runs, 43 RBI, and 56 runs. The Braves missed the playoffs that year for the first time in eight seasons.

MLB announced the latest suspension Tuesday, stating Profar violated the Joint Drug Prevention and Treatment Program. As a second offense, the penalty is 162 games without pay, forfeiting his $15 million 2026 salary. He remains under contract for 2027 at $15 million but is ineligible for any postseason or international play, including the World Baseball Classic for the Netherlands, where he was scheduled to participate. Profar, 33, from Curaçao, was scratched from a Team Netherlands exhibition game Tuesday.

The Braves issued a statement: "We were incredibly disappointed to learn that Jurickson Profar tested positive for a performance-enhancing substance and is in violation of MLB's Drug Prevention and Treatment Program. Our players are consistently educated about the Program and the consequences if they are found to be in violation. The Atlanta Braves fully support the Program."

MLB increased the second-offense penalty to a full season in 2014; Profar is the seventh player to receive such a ban, the first since Milwaukee Brewers reliever J.C. Mejia in September 2023. The suspension leaves the Braves, NL East favorites entering spring training, searching for a designated hitter option amid other injuries, including elbow surgeries for pitchers Spencer Schwellenbach and Hurston Waldrep.

人们在说什么

X discussions react with shock, frustration, and mockery to Jurickson Profar's 162-game suspension for a second PED violation involving exogenous testosterone. Braves fans lament the loss and call for roster moves, while media highlights the recurrence after his prior assurances and the substance's health impacts. Sentiments are overwhelmingly negative, with high-engagement posts from journalists confirming the news.

相关文章

Philadelphia Phillies outfielder Johan Rojas in uniform, looking serious on baseball field amid PED suspension news.
AI 生成的图像

费城人队外野手霍安·罗哈斯面临80场兴奋剂停赛

由 AI 报道 AI 生成的图像

费城人队外野手霍安·罗哈斯在休赛期兴奋剂检测呈阳性,目前正上诉80场停赛处罚。这位25岁球员原本计划代表多米尼加共和国参加世界棒球经典赛,但未报到参赛。在上诉程序持续期间,罗哈斯仍可参加春训比赛。

Major League Baseball announced on Friday that free-agent outfielder Max Kepler has received an 80-game suspension after testing positive for the performance-enhancing substance Epitrenbolone. The 32-year-old, who played last season with the Philadelphia Phillies, accepted the penalty without contest. Kepler will be ineligible for the 2026 postseason if he signs with a team.

由 AI 报道

German baseball professional Max Kepler has been suspended for 80 games by Major League Baseball. The 32-year-old from Berlin tested positive for the anabolic steroid Epitrenbolone. Kepler, who is currently without a contract, has not yet commented on the allegation.

The New York Mets have agreed to a two-year contract with infielder Jorge Polanco, formerly of the Seattle Mariners. Polanco's signing highlights his remarkable reduction in strikeout rate from 29.2% in 2024 to 15.6% in 2025, the largest single-season drop in MLB history. This improvement, driven by health recovery and swing adjustments, positions him as a contact-oriented power hitter for the Mets.

由 AI 报道

Major League Baseball announced new limits on pitch-level betting markets, capping wagers at $200 and excluding them from parlays, effective immediately across operators covering more than 98% of the U.S. market. The measures follow Sunday's federal indictment of Cleveland Guardians pitchers Emmanuel Clase and Luis Ortiz for allegedly rigging pitches to benefit gamblers. The league aims to mitigate integrity risks from these micro-bets on outcomes like balls, strikes, or pitch velocity.

As the 2026 Baseball Hall of Fame vote results approach, CBS Sports writers Matt Snyder and Mike Axisa discuss their differing ballots. Their conversation highlights debates over performance-enhancing drugs, the Astros scandal and borderline candidates. Both emphasize the challenges of drawing lines on eligibility.

由 AI 报道

Thirteen players, mostly right-handed pitchers, were selected in the Major League phase of the 2025 Rule 5 Draft held Wednesday in Orlando, Florida. The Colorado Rockies led off by taking reliever RJ Petit from the Detroit Tigers, while the Chicago White Sox made two picks. Only one position player, catcher Daniel Susac, was chosen before being traded to the San Francisco Giants.

 

 

 

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝